Standard Chemical & Pharmaceutical Co. Ltd. (TPE:1720)
57.10
-0.40 (-0.70%)
Jul 24, 2025, 1:30 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
Medicine | 3.10B | Log In | Log In | Log In | Log In | Upgrade |
Medicine Growth | 8.23% | Log In | Log In | Log In | Log In | Upgrade |
Dietary Supplement | 2.09B | Log In | Log In | Log In | Log In | Upgrade |
Dietary Supplement Growth | 7.84% | Log In | Log In | Log In | Log In | Upgrade |
Active Pharmaceutical Ingredients | 1.33B | Log In | Log In | Log In | Log In | Upgrade |
Active Pharmaceutical Ingredients Growth | 15.87% | Log In | Log In | Log In | Log In | Upgrade |
Other | 272.62M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | -6.93% | Log In | Log In | Log In | Log In | Upgrade |
Other | 272.62M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | -6.93% | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
Other | 1.04B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 154.29% | Log In | Log In | Log In | Log In | Upgrade |
Taiwan | 5.31B | Log In | Log In | Log In | Log In | Upgrade |
Taiwan Growth | 9.41% | Log In | Log In | Log In | Log In | Upgrade |
Japan | 437.03M | Log In | Log In | Log In | Log In | Upgrade |
Japan Growth | 45.54% | Log In | Log In | Log In | Log In | Upgrade |
Other | 1.04B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 154.29% | Log In | Log In | Log In | Log In | Upgrade |
South Korea | - | Log In | Log In | Log In | Log In | Upgrade |
South Korea Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Vietnam | - | Log In | Log In | Log In | Log In | Upgrade |
Vietnam Growth | - | Log In | Log In | Log In | Log In | Upgrade |
China | - | Log In | Log In | Log In | Log In | Upgrade |
China Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Saudi Arabia | - | Log In | Log In | Log In | Log In | Upgrade |
Saudi Arabia Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Germany | - | Log In | Log In | Log In | Log In | Upgrade |
Germany Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Philippines | - | Log In | Log In | Log In | Log In | Upgrade |
Philippines Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Singapore | - | Log In | Log In | Log In | Log In | Upgrade |
Singapore Growth | - | Log In | Log In | Log In | Log In | Upgrade |
United States | - | Log In | Log In | Log In | Log In | Upgrade |
United States Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Thailand | - | Log In | Log In | Log In | Log In | Upgrade |
Thailand Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Egypt | - | Log In | Log In | Log In | Log In | Upgrade |
Egypt Growth | - | Log In | Log In | Log In | Log In | Upgrade |